SAGE THERAPEUTICS INC shareholders Q2 2023

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

SAGE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
WealthPlan Investment Management, LLC 232$10,9090.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 157,000$7,382,1400.00%
Walleye Capital LLC 12,400$583,0480.00%
MORGAN STANLEY 351,911$16,546,8550.00%
Handelsbanken Fonder AB 9,744$4580.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 15,004$705,4880.00%
JANE STREET GROUP, LLC 100,362$4,719,0210.00%
Citadel Advisors 223,826$10,524,2990.00%
PRIMECAP MANAGEMENT CO/CA/ 63,600$2,990,4720.00%
GROUP ONE TRADING, L.P. 12,412$583,6120.00%
CITIGROUP INC 67,759$3,186,0280.00%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 8,938$4200.00%
Bank of New York Mellon Corp 235,668$11,081,0860.00%
FIRST TRUST ADVISORS LP 37,842$1,779,3300.00%
DekaBank Deutsche Girozentrale 22,220$1,0470.00%
STIFEL FINANCIAL CORP 38,553$1,812,7610.00%
Alberta Investment Management Corp 5,172$243,1870.00%
VICTORY CAPITAL MANAGEMENT INC 42,161$1,982,4110.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 7,914$372,1160.00%
PEAK6 Investments LLC 9,000$423,1800.00%
External links

This page lists SAGE THERAPEUTICS INC's shareholders in Q2 2023. To view SAGE THERAPEUTICS INC's shareholder history, click here.